NYSEAMERICAN:MYO - Myomo Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.67
  • Forecasted Upside: 164.23 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$8.20
▲ +0.01 (0.12%)

This chart shows the closing price for MYO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Myomo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MYO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MYO

Analyst Price Target is $21.67
▲ +164.23% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Myomo in the last 3 months. The average price target is $21.67, with a high forecast of $34.00 and a low forecast of $14.00. The average price target represents a 164.23% upside from the last price of $8.20.

This chart shows the closing price for MYO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Myomo. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/14/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/13/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/15/2021Roth CapitalReiterated RatingBuy
11/11/2021Colliers SecuritiesReiterated RatingBuy$17.00
11/11/2021Alliance Global PartnersReiterated RatingBuy$36.50 ➝ $34.00
8/10/2021Colliers SecuritiesReiterated RatingBuy$17.00
6/10/2021Alliance Global PartnersInitiated CoverageBuy
3/8/2021Colliers SecuritiesReiterated RatingBuy$16.00
1/11/2021SidotiBoost Price Target$11.00 ➝ $14.00
11/11/2020Roth CapitalUpgradeNeutral ➝ Buy$7.00
9/16/2020Colliers SecuritiesBoost Price TargetBuy$7.00 ➝ $8.00
5/27/2020Dougherty & CoReiterated RatingBuy
5/27/2020Dougherty & CoInitiated CoverageBuy$8.50
3/23/2020Ascendiant Capital MarketsLower Price TargetPositive ➝ Buy$45.00 ➝ $15.00
11/14/2019Roth CapitalDowngradeBuy ➝ Neutral
11/13/2019Roth CapitalDowngradeBuy ➝ Neutral
8/30/2019Roth CapitalSet Price TargetBuy$2.00
8/30/2019Roth CapitalLower Price TargetBuy$2.75 ➝ $1.75
7/30/2019Ascendiant Capital MarketsInitiated CoverageBuy$2.00
2/5/2019Roth CapitalReiterated RatingBuy
11/8/2018Roth CapitalReiterated RatingBuy
8/14/2018HC WainwrightSet Price TargetBuy$12.00
5/10/2018Roth CapitalSet Price TargetBuy$9.00 ➝ $7.00
5/10/2018HC WainwrightSet Price TargetBuy$12.00
3/9/2018Roth CapitalInitiated CoverageBuy$9.00
3/8/2018HC WainwrightSet Price TargetBuy$12.00
10/2/2017HC WainwrightReiterated RatingBuy
10/2/2017HC WainwrightInitiated CoverageBuy ➝ Buy$12.00
(Data available from 12/9/2016 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/12/2021
  • 3 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
8/11/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/10/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2021
  • 1 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
11/9/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/9/2021

Current Sentiment

  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Myomo logo
Myomo, Inc. is a medical robotics company, which offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It offers MyoPro, which is a myoelectric elbow, wrist, and hand orthosis that supports an impaired hand and arm while also enabling it to move again. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Read More

Today's Range

Now: $8.20
Low: $8.01
High: $8.40

50 Day Range

MA: N/A

52 Week Range

Now: $8.20
Low: $6.20
High: $18.88

Volume

16,775 shs

Average Volume

106,911 shs

Market Capitalization

$56.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Frequently Asked Questions

What sell-side analysts currently cover shares of Myomo?

The following Wall Street sell-side analysts have issued research reports on Myomo in the last twelve months: Alliance Global Partners, Colliers Securities, Roth Capital, Sidoti, and Zacks Investment Research.
View the latest analyst ratings for MYO.

What is the current price target for Myomo?

3 Wall Street analysts have set twelve-month price targets for Myomo in the last year. Their average twelve-month price target is $21.67, suggesting a possible upside of 164.6%. Alliance Global Partners has the highest price target set, predicting MYO will reach $34.00 in the next twelve months. Sidoti has the lowest price target set, forecasting a price of $14.00 for Myomo in the next year.
View the latest price targets for MYO.

What is the current consensus analyst rating for Myomo?

Myomo currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MYO will outperform the market and that investors should add to their positions of Myomo.
View the latest ratings for MYO.

How do I contact Myomo's investor relations team?

Myomo's physical mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company's listed phone number is (617) 996-9058 and its investor relations email address is [email protected] The official website for Myomo is myomo.com.